| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |